218 related articles for article (PubMed ID: 32664946)
1. Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients- the BReast cancer EXercise InTervention (BREXIT) trial protocol.
Foulkes SJ; Howden EJ; Antill Y; Loi S; Salim A; Haykowsky MJ; Daly RM; Fraser SF; La Gerche A
BMC Cancer; 2020 Jul; 20(1):655. PubMed ID: 32664946
[TBL] [Abstract][Full Text] [Related]
2. Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study.
Foulkes SJ; Howden EJ; Haykowsky MJ; Antill Y; Salim A; Nightingale SS; Loi S; Claus P; Janssens K; Mitchell AM; Wright L; Costello BT; Lindqvist A; Burnham L; Wallace I; Daly RM; Fraser SF; La Gerche A
Circulation; 2023 Feb; 147(7):532-545. PubMed ID: 36342348
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.
Kirkham AA; Paterson DI; Prado CM; Mackey JR; Courneya KS; Pituskin E; Thompson RB
BMC Cancer; 2018 Sep; 18(1):864. PubMed ID: 30176834
[TBL] [Abstract][Full Text] [Related]
5. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial.
Antunes P; Esteves D; Nunes C; Sampaio F; Ascensão A; Vilela E; Teixeira M; Amarelo AL; Joaquim A
Trials; 2019 Jul; 20(1):433. PubMed ID: 31307527
[TBL] [Abstract][Full Text] [Related]
6. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients.
Howden EJ; Bigaran A; Beaudry R; Fraser S; Selig S; Foulkes S; Antill Y; Nightingale S; Loi S; Haykowsky MJ; La Gerche A
Eur J Prev Cardiol; 2019 Feb; 26(3):305-315. PubMed ID: 30376366
[TBL] [Abstract][Full Text] [Related]
7. Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy.
Foulkes SJ; Howden EJ; Bigaran A; Janssens K; Antill Y; Loi S; Claus P; Haykowsky MJ; Daly RM; Fraser SF; LA Gerche A
Med Sci Sports Exerc; 2019 Aug; 51(8):1573-1581. PubMed ID: 30829962
[TBL] [Abstract][Full Text] [Related]
8. Effects of exercise training on cardiac toxicity markers in women with breast cancer undergoing chemotherapy with anthracyclines: a randomized controlled trial.
Antunes P; Joaquim A; Sampaio F; Nunes C; Ascensão A; Vilela E; Teixeira M; Capela A; Amarelo A; Marques C; Viamonte S; Alves A; Esteves D
Eur J Prev Cardiol; 2023 Jul; 30(9):844-855. PubMed ID: 36857149
[TBL] [Abstract][Full Text] [Related]
9. Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.
Koelwyn GJ; Lewis NC; Ellard SL; Jones LW; Gelinas JC; Rolf JD; Melzer B; Thomas SM; Douglas PS; Khouri MG; Eves ND
Oncologist; 2016 Feb; 21(2):141-9. PubMed ID: 26764251
[TBL] [Abstract][Full Text] [Related]
10. A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.
Jacquinot Q; Meneveau N; Chatot M; Bonnetain F; Degano B; Bouhaddi M; Dumoulin G; Vernerey D; Pivot X; Mougin F
BMC Cancer; 2017 Jun; 17(1):425. PubMed ID: 28629338
[TBL] [Abstract][Full Text] [Related]
11. Effects of high-intensity interval training on vascular function in breast cancer survivors undergoing anthracycline chemotherapy: design of a pilot study.
Lee K; Kang I; Mortimer JE; Sattler F; Mack WJ; Fitzsimons LA; Salem G; Dieli-Conwright CM
BMJ Open; 2018 Jun; 8(6):e022622. PubMed ID: 29961039
[TBL] [Abstract][Full Text] [Related]
12. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol.
Dillon HT; Saner NJ; Ilsley T; Kliman D; Spencer A; Avery S; Dunstan DW; Daly RM; Fraser SF; Owen N; Lynch BM; Kingwell BA; La Gerche A; Howden EJ
BMC Cancer; 2022 Aug; 22(1):898. PubMed ID: 35978289
[TBL] [Abstract][Full Text] [Related]
13. Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness.
Foulkes S; Costello BT; Howden EJ; Janssens K; Dillon H; Toro C; Claus P; Fraser SF; Daly RM; Elliott DA; Conyers R; La Gerche A
J Cardiovasc Magn Reson; 2020 Sep; 22(1):64. PubMed ID: 32892749
[TBL] [Abstract][Full Text] [Related]
14. Effects of physical exercise on outcomes of cardiac (dys)function in women with breast cancer undergoing anthracycline or trastuzumab treatment: study protocol for a systematic review.
Antunes P; Esteves D; Nunes C; Amarelo A; Fonseca-Moutinho J; Afreixo V; Costa H; Alves A; Joaquim A
Syst Rev; 2019 Oct; 8(1):239. PubMed ID: 31651372
[TBL] [Abstract][Full Text] [Related]
15. Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity.
Henriksen PA; Hall P; Oikonomidou O; MacPherson IR; Maclean M; Lewis S; McVicars H; Broom A; Scott F; McKay P; Borley A; Rowntree C; Lord S; Collins G; Radford J; Guppy A; Payne JR; Newby DE; Mills NL; Lang NN
Circ Heart Fail; 2022 Jul; 15(7):e009445. PubMed ID: 35766037
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
[TBL] [Abstract][Full Text] [Related]
17. The impact of high-intensity interval training exercise on breast cancer survivors: a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems.
Toohey K; Pumpa K; McKune A; Cooke J; Welvaert M; Northey J; Quinlan C; Semple S
BMC Cancer; 2020 Aug; 20(1):787. PubMed ID: 32819304
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Exercise on Cardiotoxicity in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy: A Systematic Review and Meta-Analysis.
Chiang CH; Chang YC; Haw Y; Tan JY; Chiang CH; Hsia YP; Chiang CH
Oncology; 2024; 102(6):510-514. PubMed ID: 38104536
[TBL] [Abstract][Full Text] [Related]
19. Home-Based Buddhist Walking Meditation Mitigates Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial.
Siripanya S; Parinyanitikul N; Tanaka H; Suksom D
J Integr Complement Med; 2023 Sep; 29(9):562-573. PubMed ID: 37036793
[No Abstract] [Full Text] [Related]
20. Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial.
Hao W; Liu S; Qin Y; Sun C; Chen L; Wu C; Bao Y
Trials; 2017 Aug; 18(1):386. PubMed ID: 28830541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]